GL1X · GenesisL1 explorer

MolNFT v1 · #127377 · protein

Crystal structure of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds

5MUT · Dihydroorotate dehydrogenase (quinone), mitochondrial: “Crystal structure of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole…”. X-ray diffraction, 4 ligands (FMN, ORO, HYT), 3 pockets (best…

PDB
5MUT
Type
protein
Length
350 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase (quinone), mitochondrial
EC
1.3.5.2
UniProt
Q02127
Ligands
FMN, ORO, HYT, CL
Pockets
3 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase (quinone), mitochondrial (EC 1.3.5.2)protein35047% helix, 17% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • HYT · 2-methyl-5-oxidanyl-~{N}-[2,3,5,6-tetrakis(fluoranyl)-4-phenyl-phenyl]-1,2,3-triazole-4-carboxamide · ligand · chains A
  • CL · Chloride ion · ion · 3 copies · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15710.800.8676FMN, ORO, HYT
21090.420.7723ACT
31060.350.7423empty

Compared structures

  • 5MUT · Crystal structure of potent human Dihydroorotate Dehydrogenase inhibitors based on… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.